nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—Dinoprostone—Bimatoprost—glaucoma	0.748	1	CrCrCtD
Lubiprostone—CLCN2—endothelium—glaucoma	0.0141	0.593	CbGeAlD
Lubiprostone—CLCN2—eye—glaucoma	0.0069	0.291	CbGeAlD
Lubiprostone—Dinoprostone—PTGFR—glaucoma	0.00443	1	CrCbGaD
Lubiprostone—CBR1—Treprostinil—Latanoprost—glaucoma	0.00407	1	CbGdCrCtD
Lubiprostone—CBR1—eye—glaucoma	0.00277	0.117	CbGeAlD
Lubiprostone—Rash—Latanoprost—glaucoma	0.000332	0.00152	CcSEcCtD
Lubiprostone—Dermatitis—Latanoprost—glaucoma	0.000331	0.00152	CcSEcCtD
Lubiprostone—Dyspepsia—Acetazolamide—glaucoma	0.000331	0.00152	CcSEcCtD
Lubiprostone—Tachycardia—Brinzolamide—glaucoma	0.000331	0.00152	CcSEcCtD
Lubiprostone—Mediastinal disorder—Clonidine—glaucoma	0.00033	0.00152	CcSEcCtD
Lubiprostone—Headache—Latanoprost—glaucoma	0.00033	0.00151	CcSEcCtD
Lubiprostone—Skin disorder—Brinzolamide—glaucoma	0.000329	0.00151	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000329	0.00151	CcSEcCtD
Lubiprostone—Anorexia—Dorzolamide—glaucoma	0.000329	0.00151	CcSEcCtD
Lubiprostone—Decreased appetite—Acetazolamide—glaucoma	0.000327	0.0015	CcSEcCtD
Lubiprostone—Oedema—Pilocarpine—glaucoma	0.000326	0.0015	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000325	0.00149	CcSEcCtD
Lubiprostone—Fatigue—Acetazolamide—glaucoma	0.000324	0.00149	CcSEcCtD
Lubiprostone—Nausea—Methazolamide—glaucoma	0.000323	0.00148	CcSEcCtD
Lubiprostone—Dyspnoea—Brimonidine—glaucoma	0.000322	0.00148	CcSEcCtD
Lubiprostone—Mental disorder—Clonidine—glaucoma	0.000321	0.00147	CcSEcCtD
Lubiprostone—Shock—Pilocarpine—glaucoma	0.000321	0.00147	CcSEcCtD
Lubiprostone—Erythema—Clonidine—glaucoma	0.000319	0.00146	CcSEcCtD
Lubiprostone—Tachycardia—Pilocarpine—glaucoma	0.000318	0.00146	CcSEcCtD
Lubiprostone—Dyspepsia—Brimonidine—glaucoma	0.000318	0.00146	CcSEcCtD
Lubiprostone—Hyperhidrosis—Pilocarpine—glaucoma	0.000315	0.00145	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000314	0.00144	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Travoprost—glaucoma	0.000313	0.00144	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Brimonidine—glaucoma	0.000312	0.00143	CcSEcCtD
Lubiprostone—Fatigue—Brimonidine—glaucoma	0.000311	0.00143	CcSEcCtD
Lubiprostone—Anorexia—Pilocarpine—glaucoma	0.000311	0.00143	CcSEcCtD
Lubiprostone—Feeling abnormal—Acetazolamide—glaucoma	0.00031	0.00142	CcSEcCtD
Lubiprostone—Hypersensitivity—Apraclonidine—glaucoma	0.00031	0.00142	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000309	0.00142	CcSEcCtD
Lubiprostone—Pain—Brimonidine—glaucoma	0.000309	0.00142	CcSEcCtD
Lubiprostone—Dyspnoea—Dorzolamide—glaucoma	0.000307	0.00141	CcSEcCtD
Lubiprostone—Muscle spasms—Clonidine—glaucoma	0.000307	0.00141	CcSEcCtD
Lubiprostone—Dyspnoea—Travoprost—glaucoma	0.000306	0.00141	CcSEcCtD
Lubiprostone—Dyspepsia—Dorzolamide—glaucoma	0.000304	0.00139	CcSEcCtD
Lubiprostone—Dyspnoea—Brinzolamide—glaucoma	0.000302	0.00139	CcSEcCtD
Lubiprostone—Dyspepsia—Travoprost—glaucoma	0.000302	0.00139	CcSEcCtD
Lubiprostone—Asthenia—Apraclonidine—glaucoma	0.000302	0.00139	CcSEcCtD
Lubiprostone—Decreased appetite—Dorzolamide—glaucoma	0.0003	0.00138	CcSEcCtD
Lubiprostone—Tremor—Clonidine—glaucoma	0.000299	0.00137	CcSEcCtD
Lubiprostone—Dyspepsia—Brinzolamide—glaucoma	0.000298	0.00137	CcSEcCtD
Lubiprostone—Fatigue—Dorzolamide—glaucoma	0.000297	0.00137	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000297	0.00136	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Travoprost—glaucoma	0.000296	0.00136	CcSEcCtD
Lubiprostone—Fatigue—Travoprost—glaucoma	0.000296	0.00136	CcSEcCtD
Lubiprostone—Ill-defined disorder—Clonidine—glaucoma	0.000296	0.00136	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000296	0.119	CbGpPWpGaD
Lubiprostone—Pain—Dorzolamide—glaucoma	0.000295	0.00135	CcSEcCtD
Lubiprostone—Decreased appetite—Brinzolamide—glaucoma	0.000295	0.00135	CcSEcCtD
Lubiprostone—Pain—Travoprost—glaucoma	0.000294	0.00135	CcSEcCtD
Lubiprostone—Constipation—Travoprost—glaucoma	0.000294	0.00135	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000293	0.00134	CcSEcCtD
Lubiprostone—Asthenia—Bimatoprost—glaucoma	0.000293	0.00134	CcSEcCtD
Lubiprostone—Fatigue—Brinzolamide—glaucoma	0.000292	0.00134	CcSEcCtD
Lubiprostone—Dyspnoea—Pilocarpine—glaucoma	0.000291	0.00133	CcSEcCtD
Lubiprostone—Pain—Brinzolamide—glaucoma	0.00029	0.00133	CcSEcCtD
Lubiprostone—Diarrhoea—Apraclonidine—glaucoma	0.000288	0.00132	CcSEcCtD
Lubiprostone—Malaise—Clonidine—glaucoma	0.000288	0.00132	CcSEcCtD
Lubiprostone—Mediastinal disorder—Betaxolol—glaucoma	0.000287	0.00132	CcSEcCtD
Lubiprostone—Dyspepsia—Pilocarpine—glaucoma	0.000287	0.00132	CcSEcCtD
Lubiprostone—Syncope—Clonidine—glaucoma	0.000286	0.00131	CcSEcCtD
Lubiprostone—Feeling abnormal—Dorzolamide—glaucoma	0.000284	0.00131	CcSEcCtD
Lubiprostone—Decreased appetite—Pilocarpine—glaucoma	0.000283	0.0013	CcSEcCtD
Lubiprostone—Feeling abnormal—Travoprost—glaucoma	0.000283	0.0013	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Dorzolamide—glaucoma	0.000282	0.0013	CcSEcCtD
Lubiprostone—Palpitations—Clonidine—glaucoma	0.000282	0.00129	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000281	0.00129	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Travoprost—glaucoma	0.000281	0.00129	CcSEcCtD
Lubiprostone—Loss of consciousness—Clonidine—glaucoma	0.00028	0.00129	CcSEcCtD
Lubiprostone—Feeling abnormal—Brinzolamide—glaucoma	0.000279	0.00128	CcSEcCtD
Lubiprostone—Mental disorder—Betaxolol—glaucoma	0.000279	0.00128	CcSEcCtD
Lubiprostone—Pain—Pilocarpine—glaucoma	0.000279	0.00128	CcSEcCtD
Lubiprostone—Constipation—Pilocarpine—glaucoma	0.000279	0.00128	CcSEcCtD
Lubiprostone—Cough—Clonidine—glaucoma	0.000278	0.00128	CcSEcCtD
Lubiprostone—Dizziness—Apraclonidine—glaucoma	0.000278	0.00128	CcSEcCtD
Lubiprostone—Malnutrition—Betaxolol—glaucoma	0.000278	0.00128	CcSEcCtD
Lubiprostone—Erythema—Betaxolol—glaucoma	0.000278	0.00128	CcSEcCtD
Lubiprostone—Abdominal pain—Dorzolamide—glaucoma	0.000273	0.00125	CcSEcCtD
Lubiprostone—Dysgeusia—Betaxolol—glaucoma	0.000272	0.00125	CcSEcCtD
Lubiprostone—Chest pain—Clonidine—glaucoma	0.000271	0.00125	CcSEcCtD
Lubiprostone—Abdominal pain—Travoprost—glaucoma	0.000271	0.00125	CcSEcCtD
Lubiprostone—Anxiety—Clonidine—glaucoma	0.000271	0.00124	CcSEcCtD
Lubiprostone—Asthenia—Acetazolamide—glaucoma	0.00027	0.00124	CcSEcCtD
Lubiprostone—Dizziness—Bimatoprost—glaucoma	0.00027	0.00124	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00027	0.00124	CcSEcCtD
Lubiprostone—Feeling abnormal—Pilocarpine—glaucoma	0.000269	0.00123	CcSEcCtD
Lubiprostone—Discomfort—Clonidine—glaucoma	0.000268	0.00123	CcSEcCtD
Lubiprostone—Vomiting—Apraclonidine—glaucoma	0.000267	0.00123	CcSEcCtD
Lubiprostone—Muscle spasms—Betaxolol—glaucoma	0.000267	0.00123	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Pilocarpine—glaucoma	0.000266	0.00122	CcSEcCtD
Lubiprostone—Hypersensitivity—Brimonidine—glaucoma	0.000266	0.00122	CcSEcCtD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—glaucoma	0.000266	0.107	CbGpPWpGaD
Lubiprostone—Dry mouth—Clonidine—glaucoma	0.000265	0.00122	CcSEcCtD
Lubiprostone—Dermatitis—Apraclonidine—glaucoma	0.000265	0.00122	CcSEcCtD
Lubiprostone—Headache—Apraclonidine—glaucoma	0.000263	0.00121	CcSEcCtD
Lubiprostone—Oedema—Clonidine—glaucoma	0.00026	0.0012	CcSEcCtD
Lubiprostone—Tremor—Betaxolol—glaucoma	0.00026	0.00119	CcSEcCtD
Lubiprostone—Asthenia—Brimonidine—glaucoma	0.000259	0.00119	CcSEcCtD
Lubiprostone—Abdominal pain—Pilocarpine—glaucoma	0.000258	0.00118	CcSEcCtD
Lubiprostone—Ill-defined disorder—Betaxolol—glaucoma	0.000258	0.00118	CcSEcCtD
Lubiprostone—Diarrhoea—Acetazolamide—glaucoma	0.000257	0.00118	CcSEcCtD
Lubiprostone—Rash—Bimatoprost—glaucoma	0.000257	0.00118	CcSEcCtD
Lubiprostone—Dermatitis—Bimatoprost—glaucoma	0.000257	0.00118	CcSEcCtD
Lubiprostone—Oedema peripheral—Timolol—glaucoma	0.000257	0.00118	CcSEcCtD
Lubiprostone—Shock—Clonidine—glaucoma	0.000256	0.00118	CcSEcCtD
Lubiprostone—Connective tissue disorder—Timolol—glaucoma	0.000256	0.00118	CcSEcCtD
Lubiprostone—Headache—Bimatoprost—glaucoma	0.000255	0.00117	CcSEcCtD
Lubiprostone—Nervous system disorder—Clonidine—glaucoma	0.000255	0.00117	CcSEcCtD
Lubiprostone—Hypersensitivity—Dorzolamide—glaucoma	0.000254	0.00117	CcSEcCtD
Lubiprostone—Tachycardia—Clonidine—glaucoma	0.000254	0.00117	CcSEcCtD
Lubiprostone—Hypersensitivity—Travoprost—glaucoma	0.000253	0.00116	CcSEcCtD
Lubiprostone—Skin disorder—Clonidine—glaucoma	0.000253	0.00116	CcSEcCtD
Lubiprostone—Hyperhidrosis—Clonidine—glaucoma	0.000252	0.00116	CcSEcCtD
Lubiprostone—Malaise—Betaxolol—glaucoma	0.00025	0.00115	CcSEcCtD
Lubiprostone—Nausea—Apraclonidine—glaucoma	0.00025	0.00115	CcSEcCtD
Lubiprostone—Hypersensitivity—Brinzolamide—glaucoma	0.00025	0.00115	CcSEcCtD
Lubiprostone—Syncope—Betaxolol—glaucoma	0.000249	0.00114	CcSEcCtD
Lubiprostone—Dizziness—Acetazolamide—glaucoma	0.000249	0.00114	CcSEcCtD
Lubiprostone—Anorexia—Clonidine—glaucoma	0.000248	0.00114	CcSEcCtD
Lubiprostone—Asthenia—Dorzolamide—glaucoma	0.000247	0.00114	CcSEcCtD
Lubiprostone—Asthenia—Travoprost—glaucoma	0.000246	0.00113	CcSEcCtD
Lubiprostone—Palpitations—Betaxolol—glaucoma	0.000245	0.00113	CcSEcCtD
Lubiprostone—Loss of consciousness—Betaxolol—glaucoma	0.000244	0.00112	CcSEcCtD
Lubiprostone—Asthenia—Brinzolamide—glaucoma	0.000243	0.00112	CcSEcCtD
Lubiprostone—Cough—Betaxolol—glaucoma	0.000242	0.00111	CcSEcCtD
Lubiprostone—Nausea—Bimatoprost—glaucoma	0.000242	0.00111	CcSEcCtD
Lubiprostone—Hypersensitivity—Pilocarpine—glaucoma	0.00024	0.0011	CcSEcCtD
Lubiprostone—Vomiting—Acetazolamide—glaucoma	0.000239	0.0011	CcSEcCtD
Lubiprostone—Dizziness—Brimonidine—glaucoma	0.000239	0.0011	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Clonidine—glaucoma	0.000237	0.00109	CcSEcCtD
Lubiprostone—Chest pain—Betaxolol—glaucoma	0.000236	0.00109	CcSEcCtD
Lubiprostone—Myalgia—Betaxolol—glaucoma	0.000236	0.00109	CcSEcCtD
Lubiprostone—Diarrhoea—Dorzolamide—glaucoma	0.000236	0.00108	CcSEcCtD
Lubiprostone—Headache—Acetazolamide—glaucoma	0.000236	0.00108	CcSEcCtD
Lubiprostone—Anxiety—Betaxolol—glaucoma	0.000236	0.00108	CcSEcCtD
Lubiprostone—Diarrhoea—Travoprost—glaucoma	0.000235	0.00108	CcSEcCtD
Lubiprostone—Mediastinal disorder—Timolol—glaucoma	0.000235	0.00108	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000235	0.00108	CcSEcCtD
Lubiprostone—Asthenia—Pilocarpine—glaucoma	0.000234	0.00107	CcSEcCtD
Lubiprostone—Discomfort—Betaxolol—glaucoma	0.000233	0.00107	CcSEcCtD
Lubiprostone—Dyspnoea—Clonidine—glaucoma	0.000232	0.00107	CcSEcCtD
Lubiprostone—Diarrhoea—Brinzolamide—glaucoma	0.000232	0.00107	CcSEcCtD
Lubiprostone—Dry mouth—Betaxolol—glaucoma	0.000231	0.00106	CcSEcCtD
Lubiprostone—Mental disorder—Timolol—glaucoma	0.000228	0.00105	CcSEcCtD
Lubiprostone—Dizziness—Dorzolamide—glaucoma	0.000228	0.00105	CcSEcCtD
Lubiprostone—Rash—Brimonidine—glaucoma	0.000228	0.00105	CcSEcCtD
Lubiprostone—Dermatitis—Brimonidine—glaucoma	0.000227	0.00104	CcSEcCtD
Lubiprostone—Dizziness—Travoprost—glaucoma	0.000227	0.00104	CcSEcCtD
Lubiprostone—Erythema—Timolol—glaucoma	0.000227	0.00104	CcSEcCtD
Lubiprostone—Malnutrition—Timolol—glaucoma	0.000227	0.00104	CcSEcCtD
Lubiprostone—Oedema—Betaxolol—glaucoma	0.000227	0.00104	CcSEcCtD
Lubiprostone—Headache—Brimonidine—glaucoma	0.000226	0.00104	CcSEcCtD
Lubiprostone—Decreased appetite—Clonidine—glaucoma	0.000226	0.00104	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Clonidine—glaucoma	0.000225	0.00103	CcSEcCtD
Lubiprostone—Fatigue—Clonidine—glaucoma	0.000224	0.00103	CcSEcCtD
Lubiprostone—Dizziness—Brinzolamide—glaucoma	0.000224	0.00103	CcSEcCtD
Lubiprostone—Nausea—Acetazolamide—glaucoma	0.000223	0.00103	CcSEcCtD
Lubiprostone—Diarrhoea—Pilocarpine—glaucoma	0.000223	0.00102	CcSEcCtD
Lubiprostone—Shock—Betaxolol—glaucoma	0.000223	0.00102	CcSEcCtD
Lubiprostone—Pain—Clonidine—glaucoma	0.000223	0.00102	CcSEcCtD
Lubiprostone—Constipation—Clonidine—glaucoma	0.000223	0.00102	CcSEcCtD
Lubiprostone—Nervous system disorder—Betaxolol—glaucoma	0.000222	0.00102	CcSEcCtD
Lubiprostone—Dysgeusia—Timolol—glaucoma	0.000222	0.00102	CcSEcCtD
Lubiprostone—Tachycardia—Betaxolol—glaucoma	0.000221	0.00102	CcSEcCtD
Lubiprostone—Skin disorder—Betaxolol—glaucoma	0.00022	0.00101	CcSEcCtD
Lubiprostone—Vomiting—Dorzolamide—glaucoma	0.000219	0.00101	CcSEcCtD
Lubiprostone—Hyperhidrosis—Betaxolol—glaucoma	0.000219	0.00101	CcSEcCtD
Lubiprostone—Rash—Dorzolamide—glaucoma	0.000217	0.000999	CcSEcCtD
Lubiprostone—Dermatitis—Dorzolamide—glaucoma	0.000217	0.000998	CcSEcCtD
Lubiprostone—Rash—Travoprost—glaucoma	0.000216	0.000994	CcSEcCtD
Lubiprostone—Dermatitis—Travoprost—glaucoma	0.000216	0.000994	CcSEcCtD
Lubiprostone—Headache—Dorzolamide—glaucoma	0.000216	0.000992	CcSEcCtD
Lubiprostone—Anorexia—Betaxolol—glaucoma	0.000216	0.000992	CcSEcCtD
Lubiprostone—Vomiting—Brinzolamide—glaucoma	0.000216	0.00099	CcSEcCtD
Lubiprostone—Dizziness—Pilocarpine—glaucoma	0.000215	0.00099	CcSEcCtD
Lubiprostone—Headache—Travoprost—glaucoma	0.000215	0.000988	CcSEcCtD
Lubiprostone—Nausea—Brimonidine—glaucoma	0.000214	0.000985	CcSEcCtD
Lubiprostone—Feeling abnormal—Clonidine—glaucoma	0.000214	0.000985	CcSEcCtD
Lubiprostone—Rash—Brinzolamide—glaucoma	0.000214	0.000982	CcSEcCtD
Lubiprostone—Dermatitis—Brinzolamide—glaucoma	0.000214	0.000981	CcSEcCtD
Lubiprostone—CBR1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000213	0.086	CbGpPWpGaD
Lubiprostone—Gastrointestinal pain—Clonidine—glaucoma	0.000213	0.000977	CcSEcCtD
Lubiprostone—Headache—Brinzolamide—glaucoma	0.000212	0.000976	CcSEcCtD
Lubiprostone—Vomiting—Pilocarpine—glaucoma	0.000207	0.000952	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000206	0.000948	CcSEcCtD
Lubiprostone—Abdominal pain—Clonidine—glaucoma	0.000206	0.000945	CcSEcCtD
Lubiprostone—Rash—Pilocarpine—glaucoma	0.000205	0.000944	CcSEcCtD
Lubiprostone—Dermatitis—Pilocarpine—glaucoma	0.000205	0.000943	CcSEcCtD
Lubiprostone—Nausea—Dorzolamide—glaucoma	0.000205	0.000941	CcSEcCtD
Lubiprostone—Headache—Pilocarpine—glaucoma	0.000204	0.000938	CcSEcCtD
Lubiprostone—Nausea—Travoprost—glaucoma	0.000204	0.000937	CcSEcCtD
Lubiprostone—Syncope—Timolol—glaucoma	0.000203	0.000934	CcSEcCtD
Lubiprostone—Dyspnoea—Betaxolol—glaucoma	0.000202	0.000928	CcSEcCtD
Lubiprostone—Nausea—Brinzolamide—glaucoma	0.000201	0.000925	CcSEcCtD
Lubiprostone—Palpitations—Timolol—glaucoma	0.0002	0.00092	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.0002	0.0806	CbGpPWpGaD
Lubiprostone—Dyspepsia—Betaxolol—glaucoma	0.000199	0.000916	CcSEcCtD
Lubiprostone—Loss of consciousness—Timolol—glaucoma	0.000199	0.000916	CcSEcCtD
Lubiprostone—Cough—Timolol—glaucoma	0.000198	0.000909	CcSEcCtD
Lubiprostone—Decreased appetite—Betaxolol—glaucoma	0.000197	0.000905	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Betaxolol—glaucoma	0.000196	0.000898	CcSEcCtD
Lubiprostone—Fatigue—Betaxolol—glaucoma	0.000195	0.000897	CcSEcCtD
Lubiprostone—Pain—Betaxolol—glaucoma	0.000194	0.00089	CcSEcCtD
Lubiprostone—Constipation—Betaxolol—glaucoma	0.000194	0.00089	CcSEcCtD
Lubiprostone—Nausea—Pilocarpine—glaucoma	0.000194	0.000889	CcSEcCtD
Lubiprostone—Chest pain—Timolol—glaucoma	0.000193	0.000887	CcSEcCtD
Lubiprostone—Myalgia—Timolol—glaucoma	0.000193	0.000887	CcSEcCtD
Lubiprostone—Anxiety—Timolol—glaucoma	0.000192	0.000884	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000192	0.000881	CcSEcCtD
Lubiprostone—Hypersensitivity—Clonidine—glaucoma	0.000192	0.000881	CcSEcCtD
Lubiprostone—Discomfort—Timolol—glaucoma	0.000191	0.000876	CcSEcCtD
Lubiprostone—Dry mouth—Timolol—glaucoma	0.000189	0.000867	CcSEcCtD
Lubiprostone—Asthenia—Clonidine—glaucoma	0.000187	0.000858	CcSEcCtD
Lubiprostone—Feeling abnormal—Betaxolol—glaucoma	0.000187	0.000858	CcSEcCtD
Lubiprostone—Oedema—Timolol—glaucoma	0.000185	0.00085	CcSEcCtD
Lubiprostone—Shock—Timolol—glaucoma	0.000182	0.000836	CcSEcCtD
Lubiprostone—Nervous system disorder—Timolol—glaucoma	0.000182	0.000834	CcSEcCtD
Lubiprostone—Skin disorder—Timolol—glaucoma	0.00018	0.000826	CcSEcCtD
Lubiprostone—Hyperhidrosis—Timolol—glaucoma	0.000179	0.000822	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—SLC6A13—glaucoma	0.000178	0.0719	CbGpPWpGaD
Lubiprostone—Diarrhoea—Clonidine—glaucoma	0.000178	0.000818	CcSEcCtD
Lubiprostone—Anorexia—Timolol—glaucoma	0.000176	0.00081	CcSEcCtD
Lubiprostone—Dizziness—Clonidine—glaucoma	0.000172	0.00079	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Timolol—glaucoma	0.000169	0.000775	CcSEcCtD
Lubiprostone—Hypersensitivity—Betaxolol—glaucoma	0.000167	0.000767	CcSEcCtD
Lubiprostone—Vomiting—Clonidine—glaucoma	0.000165	0.00076	CcSEcCtD
Lubiprostone—Dyspnoea—Timolol—glaucoma	0.000165	0.000758	CcSEcCtD
Lubiprostone—Rash—Clonidine—glaucoma	0.000164	0.000754	CcSEcCtD
Lubiprostone—Dermatitis—Clonidine—glaucoma	0.000164	0.000753	CcSEcCtD
Lubiprostone—Headache—Clonidine—glaucoma	0.000163	0.000749	CcSEcCtD
Lubiprostone—Dyspepsia—Timolol—glaucoma	0.000163	0.000748	CcSEcCtD
Lubiprostone—Asthenia—Betaxolol—glaucoma	0.000163	0.000747	CcSEcCtD
Lubiprostone—Decreased appetite—Timolol—glaucoma	0.000161	0.000739	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Timolol—glaucoma	0.00016	0.000734	CcSEcCtD
Lubiprostone—Fatigue—Timolol—glaucoma	0.00016	0.000733	CcSEcCtD
Lubiprostone—Pain—Timolol—glaucoma	0.000158	0.000727	CcSEcCtD
Lubiprostone—Diarrhoea—Betaxolol—glaucoma	0.000155	0.000712	CcSEcCtD
Lubiprostone—Nausea—Clonidine—glaucoma	0.000155	0.00071	CcSEcCtD
Lubiprostone—Feeling abnormal—Timolol—glaucoma	0.000153	0.000701	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Timolol—glaucoma	0.000151	0.000695	CcSEcCtD
Lubiprostone—Dizziness—Betaxolol—glaucoma	0.00015	0.000688	CcSEcCtD
Lubiprostone—Abdominal pain—Timolol—glaucoma	0.000146	0.000672	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—TXN—glaucoma	0.000146	0.0591	CbGpPWpGaD
Lubiprostone—Vomiting—Betaxolol—glaucoma	0.000144	0.000662	CcSEcCtD
Lubiprostone—Rash—Betaxolol—glaucoma	0.000143	0.000656	CcSEcCtD
Lubiprostone—Dermatitis—Betaxolol—glaucoma	0.000143	0.000656	CcSEcCtD
Lubiprostone—Headache—Betaxolol—glaucoma	0.000142	0.000652	CcSEcCtD
Lubiprostone—Hypersensitivity—Timolol—glaucoma	0.000136	0.000626	CcSEcCtD
Lubiprostone—Nausea—Betaxolol—glaucoma	0.000135	0.000618	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000133	0.0538	CbGpPWpGaD
Lubiprostone—Asthenia—Timolol—glaucoma	0.000133	0.00061	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—SLC6A1—glaucoma	0.00013	0.0526	CbGpPWpGaD
Lubiprostone—Diarrhoea—Timolol—glaucoma	0.000127	0.000582	CcSEcCtD
Lubiprostone—Dizziness—Timolol—glaucoma	0.000122	0.000562	CcSEcCtD
Lubiprostone—Vomiting—Timolol—glaucoma	0.000118	0.000541	CcSEcCtD
Lubiprostone—Rash—Timolol—glaucoma	0.000117	0.000536	CcSEcCtD
Lubiprostone—Dermatitis—Timolol—glaucoma	0.000117	0.000536	CcSEcCtD
Lubiprostone—Headache—Timolol—glaucoma	0.000116	0.000533	CcSEcCtD
Lubiprostone—Nausea—Timolol—glaucoma	0.00011	0.000505	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—TGFB2—glaucoma	0.000106	0.0429	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.75e-05	0.0394	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—PTGS2—glaucoma	9.6e-05	0.0387	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.4e-05	0.0299	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTM1—glaucoma	7.22e-05	0.0292	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CA5A—glaucoma	6.97e-05	0.0281	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NARFL—glaucoma	6.97e-05	0.0281	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CA1—glaucoma	3.4e-05	0.0137	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CTSA—glaucoma	3.3e-05	0.0133	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CA2—glaucoma	3.11e-05	0.0126	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.04e-05	0.0123	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.04e-05	0.0123	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—TXN—glaucoma	2.19e-05	0.00886	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2e-05	0.00808	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.98e-05	0.00801	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTT1—glaucoma	1.7e-05	0.00687	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.37e-05	0.00554	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP1B1—glaucoma	1.36e-05	0.00547	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ABCA1—glaucoma	1.36e-05	0.00547	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTM1—glaucoma	1.08e-05	0.00437	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—MTHFR—glaucoma	9.58e-06	0.00387	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOE—glaucoma	8.92e-06	0.0036	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CAV1—glaucoma	8.83e-06	0.00357	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NOS3—glaucoma	6.68e-06	0.0027	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PTGS2—glaucoma	6.11e-06	0.00247	CbGpPWpGaD
